The RA Paradigm Shift: New Insights into Pathogenesis and a Pipeline of Promise

Professor Elena Nikiphorou discusses the ongoing paradigm shift in rheumatoid arthritis (RA), presented at the EULAR 2026 Congress. This recap focuses on novel insights into RA pathogenesis and explores the promising therapeutic pipeline, highlighting how these scientific advancements are translating into more targeted, effective management strategies for clinical practice.

Assessment of Disease Activity in Psoriatic Arthritis

Dr. Michael Zauner provides a comprehensive expert overview of the latest advancements in assessing disease activity in Psoriatic Arthritis, presented at the EULAR 2026 Congress. This recap explores the evolving role of multi-domain assessment tools, the integration of patient-reported outcomes, and how more precise tracking measures are shaping modern treat-to-target strategies to improve long-term joint and skin outcomes.

Tired Is Not Just a State of Mind: Addressing Pathological Fatigue at EULAR 2026

Dr. Elena Elefante provides an expert look into the EULAR 2026 joint session "Tired is not just a state of mind," focusing on the clinical realities of pathological fatigue in patients with rheumatic and musculoskeletal diseases (RMDs). This overview dives into how chronic fatigue is increasingly recognized as a complex biological symptom rather than a purely psychological state. The recap explores current challenges and advancements in defining, objectively measuring, and managing this debilitating condition to improve patient quality of life.

Advanced Management in Rheumatoid Arthritis: Critical Updates from EULAR 2026

Professor Ruxandra Ionescu delivers an expert overview of the EULAR 2026 session dedicated to the advanced management of Rheumatoid Arthritis. This comprehensive recap explores the latest clinical evidence, emerging therapeutic pathways, and refined treat-to-target protocols designed to address complex, difficult-to-treat cases. The discussion highlights practical strategies for optimizing long-term outcomes, balancing drug safety, and improving overall quality of life for RA patients.

Transitioning Young Patients with Autoinflammatory Diseases to Adult Care: Implications for Daily Clinical Management

Dr. Marco Gattorno provides an essential overview of the EULAR 2026 session focused on the transition of young patients with autoinflammatory diseases from pediatric to adult rheumatology care. This recap highlights the practical and clinical implications for daily medical management, emphasizing the need for structured multidisciplinary protocols. The discussion explores how to maintain treatment continuity, empower young patients, and address the unique disease trajectories that cross the age divide.

Under the Surface: New Perspectives in Lupus with TLR7/8 Inhibition

Dr. Victoria Werth provides an expert analysis of the EULAR 2026 session exploring the role of Toll-like receptor 7 and 8 (TLR7/8) inhibition in systemic lupus erythematosus (SLE) and cutaneous lupus erythematosus (CLE). This recap looks beneath the surface at the underlying pathogenic mechanisms of the disease, highlighting the latest clinical data and new therapeutic perspectives on how targeting the TLR7/8 pathway could transform future treatment strategies and patient outcomes.

Clinical Manifestations and Disease Course in Systemic Sclerosis

Dr. Cristiana Sieiro Santos delivers a vital expert analysis on the heterogeneous clinical manifestations and unpredictable disease course of Systemic Sclerosis, featured at the EULAR 2026 Congress. This brief highlights the crucial updates in early risk stratification, the progression of organ-specific complications like interstitial lung disease (ILD), and how deep clinical phenotyping is driving the shift toward precision medicine and targeted therapeutic intervention.

Chest HRCT in Detecting, Staging and Follow Up of SARD-ILD

Dr. Muriel Elhai provides an essential expert overview of the critical role of chest high-resolution computed tomography (HRCT) in systemic autoimmune rheumatic disease-associated interstitial lung disease (SARD-ILD), presented at the EULAR 2026 Congress. This recap highlights the latest advancements in early HRCT screening protocols, radiographic staging techniques, and optimal monitoring strategies designed to accurately track disease progression and guide therapeutic decisions.

Highlights of EULAR 2026

Professor Xenofon Baraliakos, President of EULAR, delivers an authoritative executive summary of the definitive highlights from the EULAR 2026 Congress in London. Reflecting on a record-breaking year of scientific submissions, this overview captures the most impactful advancements spanning basic translational research, groundbreaking clinical trials in rheumatology, and newly updated management guidelines, emphasizing a 360-degree approach to bridging the gap between bench research and routine clinical practice.

Novel Treatment Horizons in Lupus: Key Updates from EULAR 2026

Dr. Victoria Werth provides a concise update on the rapidly evolving therapeutic landscape for lupus, highlighting breakthrough data from EULAR 2026. This recap focuses on novel, targeted therapies designed to address unmet needs in both systemic (SLE) and cutaneous lupus (CLE), exploring how these precision strategies are successfully reshaping disease modification.

From Diagnosis to Family Building: Navigating Fertility in RMDs

Dr. Laura Andreoli and Dr. Karen Schreiber share essential insights from EULAR 2026 on managing fertility and family planning in patients with rheumatic and musculoskeletal diseases (RMDs). This recap explores clinical strategies from early diagnosis to pregnancy, focusing on safe medication management, patient counseling, and the multidisciplinary support needed to ensure positive maternal and fetal outcomes.

Impact of Sonelokimab on Clinical and Imaging Outcomes in Axial Spondyloarthritis: Results of a Phase 2 Study

Professor Xenofon Baraliakos, President of EULAR, presents pivotal data from a Phase 2 study evaluating the impact of sonelokimab, an IL-17A/F-inhibiting Nanobody, on clinical outcomes in axial spondyloarthritis. Highlighted at the EULAR 2026 Congress, this breakthrough recap explores how the integration of advanced 18F-NaF PET imaging and MRI provides unprecedented visualization of reduced bone inflammation and metabolic activity, opening new pathways for targeted biologic therapies.

Novel Development in Treatment of Lupus

Dr. Anca Dinu Askanase provides an essential expert overview of the latest breakthrough advancements and novel therapeutic developments in the treatment of Systemic Lupus Erythematosus (SLE), presented at the EULAR 2026 Congress. This recap highlights the evolving paradigm of targeted biologics, innovative small molecules, and combination strategies designed to achieve deeper clinical remission, minimize steroid dependency, and prevent long-term organ damage.

Managing Comorbidities in Rheumatoid Arthritis for Better Outcome

Dr. Claudia Iannone delivers a vital expert perspective on the strategic management of comorbidities in patients with Rheumatoid Arthritis, featured at the EULAR 2026 Congress. This brief emphasizes the profound impact of cardiovascular, metabolic, and mental health conditions on RA progression, highlighting integrated care approaches and early screening protocols essential for optimizing long-term therapeutic outcomes and patient quality of life.

Managing Comorbidities in Systemic Sclerosis to Achieve Better Outcome

Dr. Claudia Iannone delivers a vital expert perspective on the strategic management of comorbidities in patients with Systemic Sclerosis, featured at the EULAR 2026 Congress. This brief emphasizes the profound impact of overlapping systemic, cardiovascular, and metabolic complications on disease progression, highlighting the integrated care approaches and proactive screening protocols essential for optimizing long-term therapeutic outcomes and patient quality of life.

Pain Management in Rheumatological Diseases

Dr. Jasminka Milas-Ahic provides a comprehensive expert overview of the contemporary challenges and advancements in pain management across rheumatological diseases, presented at the EULAR 2026 Congress. This recap explores the critical shift toward multimodal treatment strategies, the integration of pharmacological and non-pharmacological interventions, and how addressing centralized pain mechanisms is vital to improving long-term patient outcomes and quality of life.